TMSP(SH:600671)2023-10-27 16:00Financial Performance - The company's operating revenue for Q3 2023 was ¥35,153,279.68, representing a year-on-year increase of 33.02%[5] - The net profit attributable to shareholders was -¥4,036,957.67 for the quarter, with a year-to-date total of -¥27,457,999.53[6] - The basic earnings per share for Q3 2023 was -¥0.03, while the diluted earnings per share was -¥0.02[6] - The company reported a revenue of CNY 86.11 million for Q3 2023, with a net loss of CNY 27.39 million, and a net asset value of -CNY 42.09 million as of September 30, 2023[23] - Total operating revenue for the first three quarters of 2023 reached ¥86,107,172.19, an increase of 10.3% compared to ¥78,291,706.32 in the same period of 2022[28] - Net profit for the third quarter was reported at -¥27,526,126.34, an improvement from -¥34,469,771.38 in the previous year[29] - The total comprehensive income for the third quarter of 2023 was -27,526,126.34 CNY, compared to -34,469,771.38 CNY in the same period last year, showing an improvement[30] - The basic and diluted earnings per share for the third quarter were both -0.2255 CNY, compared to -0.2484 CNY in the previous year[30] Assets and Liabilities - Total assets at the end of the reporting period were ¥340,442,501.83, reflecting a 13.54% increase compared to the end of the previous year[6] - The company's total assets increased to ¥340,442,501.83 from ¥299,839,827.42, marking a growth of 13.5%[27] - Current liabilities rose to ¥292,771,437.61, up from ¥221,220,655.36, indicating a significant increase of 32.4%[26] - The total liabilities increased to ¥362,804,002.44 from ¥295,360,099.11, reflecting a rise of 22.8%[26] - The equity attributable to shareholders of the parent company showed a decline, reaching -¥260,833,486.20 compared to -¥233,375,486.67 in the previous year[26] Cash Flow - Cash flow from operating activities showed a net outflow of -¥28,882,242.08 year-to-date[6] - The company's cash and cash equivalents increased to CNY 100.95 million as of September 30, 2023, compared to CNY 42.39 million at the end of 2022[24] - Cash inflow from operating activities for the first three quarters of 2023 was 90,357,676.19 CNY, down from 97,307,694.57 CNY in the same period of 2022[32] - The net cash flow from operating activities for the first three quarters of 2023 was -28,882,242.08 CNY, worsening from -16,977,717.36 CNY in the previous year[32] - Cash inflow from financing activities for the first three quarters of 2023 was 258,308,673.78 CNY, compared to 201,403,118.00 CNY in the same period last year[33] - The net cash flow from financing activities increased to 91,706,650.91 CNY in 2023, up from 28,034,817.26 CNY in 2022[33] - The cash and cash equivalents at the end of the third quarter of 2023 totaled 100,945,911.36 CNY, significantly up from 18,685,337.77 CNY at the end of the previous year[33] Shareholder Information - The total number of common shareholders at the end of the reporting period is 7,246[13] - Qingdao Huilong Huaze Investment Co., Ltd. holds 26,799,460 shares, accounting for 22.01% of total shares[14] - Yongxin Huari Cultural Development Co., Ltd. holds 24,765,900 shares, accounting for 20.34% of total shares[14] - The company plans to issue 36,533,540 shares to Huilong Huaze, pending shareholder approval and regulatory review[15] - Yongxin Huari intends to transfer 9,720,000 shares (7.98% of total shares) to Huilong Huaze and 15,045,900 shares (12.36% of total shares) to Yuanjia Medical Technology Co., Ltd.[15] - After the transfer, Huilong Huaze will hold 36,519,460 shares, representing 29.99% of total shares, becoming the controlling shareholder[16] Management and Strategy - The company has appointed new senior management, including Mr. Xu Xuyu as General Manager and Mr. Yu Hongjian as Vice General Manager and CFO, following several resignations in September and October 2023[20] - The company’s operational strategy includes restructuring and optimizing business segments to enhance overall performance[22] - The company continues to face challenges in achieving profitability, with a significant focus on improving its financial health and operational efficiency[23] Other Financial Matters - The company received a debt waiver of CNY 90 million from its controlling shareholder, which will be recorded as capital reserve, potentially improving the company's net asset position[21] - The company resolved a violation of guarantee issue by receiving a payment of 1,118,700 RMB for interest related to a previous guarantee[17] - A commitment was made by Yongxin Huari to pay 5,289,973.78 RMB for liabilities related to a previous unauthorized guarantee[18] - The company transferred its 51% stake in Shixiu (Hangzhou) Technology Co., Ltd. for CNY 1 to optimize resource allocation, which will not significantly impact its financial results[22] - The company is at risk of delisting due to negative net assets as of the end of 2022, and it remains in a loss position as of Q3 2023[23] - The company has committed to fulfilling remaining compensation obligations related to a legal matter, with a payment of CNY 5.29 million received from a related party[19] - The company reported a significant increase in other payables, which rose to ¥135,756,905.89 from ¥50,799,257.45, indicating a growth of 167.5%[26] - The company received 270,000.00 CNY from minority shareholders as part of the investment in the third quarter[33]